Cipla Ltd - Sep 2020 sales - Angel Broking

Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Cipla Ltd clock market share of 5.1% in domestic sales for the month of September, cipla clock sales growth of 15.7% in month of September 2020 on back of Remdesivir injection (Cipremi) which is used for emergency use authorisation for patients with severe Covid-19 disease. Average Indian Pharma Market sales growth at 4.5% as per the AIOCD September data.

Shares of CIPLA LTD. was last trading in BSE at Rs.768.45 as compared to the previous close of Rs. 781.4. The total number of shares traded during the day was 133140 in over 3100 trades.

The stock hit an intraday high of Rs. 787.8 and intraday low of 762.95. The net turnover during the day was Rs. 103412731.

Source : Equity Bulls

Keywords